Care Plan Demo Dr Laura Esserman This work is licensed under a Creative Commons Attribution 3.0 Unported License. © 2007 Laura J Esserman.

Slides:

Advertisements

Similar presentations

Mammary ductal carcinoma

Advertisements

Pimp Session: Breast By James Lee, MD.

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.

Nadya Dimitrova Marieta Petkova. 13 Regional cancer registries BNCR: -Established in 1952; cases a year; million population;

Histopathology and Cytology for Breast lesions Britt-Marie Ljung MD Professor of Pathology, Dir. of Cytology University of California at San Francisco.

First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

KIDNEY CANCER By: Kendall Whitney. WHAT IS KIDNEY CANCER?  Cancer that forms in tissues of the kidneys. Kidney cancer includes cancer that forms in the.

AJCC TNM Staging 7th Edition Breast Case #3

What to Expect When a Lump Is Detected

Faculty of Medicine - Benha University

FINE - NEEDLE ASPIRATION BIOPSY By Dr. Tarek Atia.

Ductal Carcinoma in situ

Breast Cancer By George Rezk.

Breast Cancer This slide goes first.

© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.

ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.

Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.

Breast Cancer Awareness By: Dominick Phillips. What Is Breast Cancer? If a cell changes into a abnormal, sometimes harmful form, it can divide quickly.

2 years later, she noticed multiple cm

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Assessment of breast microcalcification with stereotactic guidance using the Spirotome Biopsy Needle. Comparison with other biopsy devices Dr Richard Harries.

 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

Breast Cancer Methods for Early Detection. Breast Cancer What It Is Methods of Early Detection Risk Factors.

Endometrial Carcinoma

Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.

What’s Next After an Abnormal Screening Mammogram? James A Stewart M.D. Elizabeth Burnside M.D.

Case 48 y.o. healthy woman Right breast mass present for 4 weeks No other known health problems Clinical breast examination: –Fullness visible in R breast.

EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.

The Breast Clinic Index case Year 2 Michaelmas term.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2013 – December 31, 2013 Compiled by Uzma Nazim, M.D.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

Breast Complaints You gotta know when to screen em, know when to street em, know when to reassure, know when to refer.

Treatment Summary University of California San Francisco Center of Excellence for Breast Cancer Care PI: Laura J Esserman MD MBA; Edward Mahoney; Elly.

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast.

 Among all cancers, breast cancer has been the 2 nd leading cause of death in women (right behind lung cancer)  Causes about 40,000 deaths annually.

BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.

Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2014 – December 31, 2014 Compiled by L.Day, RN BSN CCM CCRP OCN 1.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2009 – December 31, 2009.

The breast disease. Benign disease Present as; 1. Pain 2. Mass 3. Discharge 4. Abnormal appearance.

Upon completion of this lesson, you will be able to: Identify different diagnostic procedures for breast cancer screening Describe different diagnostic.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2011 – December 31, 2011 Compiled by Lynn Day, RN BSN CCM CCRP.

2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2012 – December 31, 2012 Compiled by Uzma Nazim, M.D.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2010 – December 31, 2010 Compiled by Lynn Day, RN BSN CCM CCRP.

This material is protected by United States copyright law, and includes content owned by Discovery Education, The Val Skinner Foundation, and Rutgers,

Multi Disciplinary Cancer Management –Breast Cancer Dr Masalu N. MD Medical Oncologist.

Surgery For Breast Cancer. Surgery  Surgery is the process that treats diseases or injuries by physical and instrumental means.  It can reduce the symptoms.

What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.

The most proven way to fight breast cancer is early detection!

Breast Cancer Treatment. Treatment 2 aspects 1. Treatment of the breast itself: “Local Treatment” 2. Treatment of the whole body = “Systemic treatment”

Deepam Meditours Medical Assistance Tourism Company We will FIGHT against “BREAST CANCER”……. Want to Join us….

OVERVIEW OF BREAST PATHOLOGY Shahin Sayed, MMed, FCPath(ECSA) Assistant Professor, Department of Pathology, Aga Khan University Hospital, Nairobi.

SYMPTOMS | DIAGNOSIS | TREATMENT

Ultrasound breast core needle biopsy

Ari Brooks, MD Cancer Surgeon, Big Data End User

Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya.

Dr Amit Gupta Associate Professor Dept Of Surgery

Breast Case 1 Jane McNicholas Consultant Oncoplastic Breast Surgeon

BREAST CANCER ONCOLOGY NAVIGATION SERVICE

Coordination (benign lesions)

Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT

سرطان الثدي Breast Cancer

Problem Statement GOAL: To modify the needle used during a Fine Needle Aspiration (FNA) procedure. The modification should not drastically change the.

Treatment Overview: The Multidisciplinary Team

Handling and Evaluation of Breast Cancer Biopsy

Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.

Presentation transcript:

Care Plan Demo Dr Laura Esserman This work is licensed under a Creative Commons Attribution 3.0 Unported License. © 2007 Laura J Esserman

Info Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ Elly Doe 01/01/ Main St San Francisco, Ca Phone: Cell: Insurance: Mega Heartless Insurance of America Policy#: Phone: Share My Plan with: Sister Mom Dr. G. P. Daughter Invite Share with Provider List Invite Dr. Collins Dr. Shumay Dr. Foster Events/TestsCare PlanTrialsCommunicate Treatment

Events/Tests Info Care PlanTrialsCommunicate Treatment Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ Initial Consultation & Mammogram S Eder: Patient information was collected and verified. Patient was provided with Information on breast cancer and possible Treatments. Patient was taken to imaging center for Mammogram. Mammogram shows small mass in left breast At 2 o’clock position. Recommend patient return for FNA 02/03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Events/Tests Info Care PlanTrialsCommunicate Treatment Mammogram Mammogram shows small mass in left breast At 2 o’clock position. Recommend patient return for FNA Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider: Click for larger view

Events/Tests Info Care PlanTrialsCommunicate Treatment Mammogram Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Events/Tests Info Care PlanTrialsCommunicate Treatment FNA D. Hamolsky: FNA was performed on mass at 2 o’clock position in left breast.FNA Ordered Cytology Assessment on FNA sample. Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Events/Tests Info Care PlanTrialsCommunicate Treatment FNA Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider: Definition: FNA Fine Needle Aspiration Biopsy procedure that uses a very thin, hollow needle to remove a sample of cells from the abnormal area of the breast. Also called a fine needle biopsy. Definition Close

Events/Tests Info Care PlanTrialsCommunicate Treatment Cytology Pathologist: Examined Cells from FNA sample on patient. Cells are suspicious but Not definitive for diagnosis. Recommend further tests. Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Events/Tests Info Care PlanTrialsCommunicate Treatment Core Biopsy Dr. Esserman: performed core biopsy on Mass at 2 o’clock position in left breast. Requested pathology assessment for Specimen for IDC and DCIS as well as ER/PR. Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Events/Tests Info Care PlanTrialsCommunicate Treatment Pathology Results on Core Biopsy Sample Dr. Smith: Examined Cells from Core Biopsy on patient. Cells clearly show IDC, IDC grade 2. ERER: Positive PRPR: Positive Her-2: 2+ (indeterminate) Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider: Click to enlarge

Events/Tests Info Care PlanTrialsCommunicate Treatment Pathology Results on Core Biopsy Sample Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her /03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Events/Tests Info Care PlanTrialsCommunicate Treatment Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ Initial Consultation & Mammogram S Eder: Patient information was collected and verified. Patient was provided with Information on breast cancer and possible Treatments. Patient was taken to imaging center for Mammogram. Mammogram shows small mass in left breast At 2 o’clock position. Recommend patient return for FNA 02/03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Events/Tests Info Care PlanTrialsCommunicate Treatment Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ Initial Consultation & Mammogram S Eder: Patient information was collected and verified. Patient was provided with Information on breast cancer and possible Treatments. Patient was taken to imaging center for Mammogram. Mammogram shows small mass in left breast At 2 o’clock position. Recommend patient return for FNA 02/03/2007 NP (S. Eder) 02/21/2007 CNS (D. Hamolsky) 03/07/2007 Results: Cytology 03/16/2007 Dr. (L. Esserman) 04/10/2007 Results: Pathology 02/03/2007 Results: Mammo 04/10/2007 Pending: Risk 04/10/2007 Pending: FISH Date: Event/Provider:

Care Plan Events/TestsInfoTrialsCommunicate Treatment Chemo:none Hormone:none Radiation:none Biologic:none Surgery:none RecommendedNeed more info Pending Results 4/10/2007 Risk 4/10/2007 FISH Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule

Care Plan Events/TestsInfoTrialsCommunicate Treatment Chemo:none Hormone:none Radiation:none Biologic:none Surgery:none RecommendedNeed more info Pending Results 4/10/2007 Risk 4/10/2007 FISH Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule none BCT mast.

Care Plan Events/TestsInfoTrialsCommunicate Treatment Chemo:none Hormone:none Radiation:none Biologic:none Surgery:none RecommendedNeed more info Pending Results 4/10/2007 Risk 4/10/2007 FISH Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule none BCT mast. BCT

Care Plan Events/TestsInfoTrialsCommunicate Treatment Chemo:none Hormone:none Radiation:none Biologic:none Surgery:BCT RecommendedNeed more info Pending Results 4/10/2007 Risk 4/10/2007 FISH Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule

Care Plan Events/TestsInfoTrialsCommunicate Treatment Option 1: Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back SCH Forward Option 2: AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back Forward HSC

Care Plan Events/TestsInfoTrialsCommunicate Treatment Option 1: Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back SCH Forward Option 2: AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back Forward HSC Surgery

Care Plan Events/TestsInfoTrialsCommunicate Treatment Option 1: Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back SCH Forward Option 2: AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back Forward HSC SurgeryChemotherapy

Care Plan Events/TestsInfoTrialsCommunicate Treatment Option 1: Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back SCH Forward Option 2: AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back Forward HSC SurgeryChemotherapy Hormone Therapy

Care Plan Events/TestsInfoTrialsCommunicate Treatment Option 1: Choose a date for Surgery Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ ChoicesDecisionsSchedule AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back SurgeryChemotherapy Hormone Therapy Forward Option 2: Choose a date for Surgery AprilAprilMayMayJuneJuneJulyJulyAugustAugustSeptemberSeptember OctoberOctoberNovemberNovemberDecemberDecemberJanuaryJanuaryFebruaryFebruaryMarchMarch back SurgeryChemotherapy Hormone Therapy Forward

Trials Events/TestsInfoCare PlanCommunicate Treatment Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ Tumor Bank Alfred Au After your surgery, a piece of tumor is saved for future research Breast Sympto ms Claudia West A study to identify problems such as lymphedema, nerve pain and changes in movement and strength that women may experience Hormon al Therapy for DCIS Juan Lessing This study looks at whether DCIS can be treated with 3 months of hormone blocking medications. StatinsJohn Parr Patients with DCIS or early stage breast cancer planning to undergo mastectomy will be chosen by chance to take fluvastitin TargitThea Sakata Patients will either take normal radiation therapy or radiation during surgery.

Communicate Events/TestsInfoCare PlanTrials Treatment Patient: Elly Doe DoB: 01/01/1957 (50) Summary: 2.2cm IDC, Grade II, ER +, PR +, Her-2 2+ To: UCSF Scheduler Dr Esserman Dr. Melisko Mom Health Blog 4/10/07 From: Dr. E (UCSF) About your option1, start with chemo- gives us info about response, may get you to BCT 4/11/07 From: Dr. H (Marin) Not sure you will get to BCT with option 1, you may have more DCIS, maybe surgery should come first 4/14/07 From: Aunt Ellen (Pittsburgh) I did not have treatment that way 4/22/07 URGENT! From: Dr E (UCSF) Please call me Compose message: Message: Send New Entry